oky-046 ( 30 mg/kg , intravenously ) decreased ventricular arrhythmias significantly both during 30 min of coronary artery ligation and subsequent reperfusion , which corresponded with a significant reduction of thromboxane concentration , suggesting that thromboxane released during ligation is an important factor in the development of ventricular arrhythmias .
C0085612
ventricular arrhythmias
C0003811
arrhythmias